Provided by Tiger Trade Technology Pte. Ltd.

IO Biotech, Inc.

0.2050
+0.01226.33%
Post-market: 0.1988-0.0062-3.02%16:05 EDT
Volume:922.45K
Turnover:186.60K
Market Cap:14.75M
PE:-0.15
High:0.2066
Open:0.2000
Low:0.1929
Close:0.1928
52wk High:2.79
52wk Low:0.1402
Shares:71.95M
Float Shares:31.16M
Volume Ratio:0.81
T/O Rate:2.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3356
EPS(LYR):-1.4494
ROE:-240.48%
ROA:-88.58%
PB:16.19
PE(LYR):-0.14

Loading ...

Morgan Stanley Downgrades IO Biotech to Equalweight From Overweight, Cuts Price Target to $0.39 From $4

MT Newswires Live
·
Sep 30, 2025

Hold Rating for IO Biotech Amid Regulatory and Financial Challenges

TIPRANKS
·
Sep 30, 2025

TD Cowen downgrades IO Biotech (IOBT) to a Hold

TIPRANKS
·
Sep 30, 2025

IO Biotech Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Sep 30, 2025

BUZZ-IO Biotech drops after FDA recommends another late-stage study for cancer vaccine

Reuters
·
Sep 30, 2025

H.C. Wainwright downgrades IO Biotech (IOBT) to a Hold

TIPRANKS
·
Sep 30, 2025

H.C. Wainwright downgrades IO Biotech after FDA recommends another Phase 3 trial

TIPRANKS
·
Sep 30, 2025

IO Biotech Advised Against Filing Biologics License Application for Cylembio; Plans to Cut 50% of Workforce

MT Newswires Live
·
Sep 29, 2025

FDA Recommends Against IO Biotech’s Cylembio Application

TIPRANKS
·
Sep 29, 2025

IO Biotech to Reduce Headcount by 50% Amid Restructuring

Dow Jones
·
Sep 29, 2025

BRIEF-IO Biotech Provides Update Following Pre-BLA Meeting with FDA

Reuters
·
Sep 29, 2025

IO Biotech Inc - to Reduce Workforce by About 50%

THOMSON REUTERS
·
Sep 29, 2025

IO Biotech Provides Update Following Pre-Bla Meeting With FDA

THOMSON REUTERS
·
Sep 29, 2025

IO Biotech Inc - Expects $1.0 Mln-$1.5 Mln Charge in Q3 2025

THOMSON REUTERS
·
Sep 29, 2025

IO Biotech Inc - Plans New Study for Cylembio in Melanoma

THOMSON REUTERS
·
Sep 29, 2025

IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025

GlobeNewswire
·
Sep 23, 2025